Research article · 20 Oct 2012
Conference abstractPublished 19 Jun 2013
Incidence of candidaemia and antifungal sensitivity in critically ill patients
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The incidence of invasive candidaemia is increasing all over the world, mainly in critically ill and immunocompromised patients. A shift to non-albicans species and a growing antimycotic resistance have been noticed. We analyzed the different Candida species isolated from bloodstream infections and the related antifungal susceptibility pattern over a three year period at Policlinico Umberto I of Rome. 7574 blood cultures were tested from 2009 to 2011 . The overall incidence of invasive candidaemia during the three years under study was about 4.75% with a marked increase from 2009 to 2011 (3.85% to 7.5%). The species isolated were the following: C. albicans 37.6% and non-albicans 62.4% (C. krusei 30.2%, C. glabrata 21.7%, C. parapsilosis 5.6%, C. tropicalis 3.8% and C. lusitaniae 1.1%). C. albicans showed a growing resistance to amphotericin B (from 0% in 2009 to 6.6% in 2011) and voriconazole (from 0% in 2009 to 13.4% in 2011). C. krusei exhibited a raising resistance to amphotericin B, itraconazole and voriconazole (from 0% to 40%, from 25% to 50%, from 0% to 20%, respectively). All C. krusei resulted to be resistant to fluconazole (intrinsic resistance). In C. glabrata a marked increased of resistance to all the antifungal agents was observed. In vitro activity of the echinocandins resulted to be very strong for all Candida species. Our study confirms the high incidence of candidaemia (especially C. albicans) in the setting of critically ill patients.. The overall rate of resistance increased over the study period in all the Candida strains.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 28 Feb 2023
The Incidence of Propofol Infusion Syndrome in Critically Ill Patients
Research article · 18 Apr 2022
Incidence and Outcomes of Invasive Pulmonary Aspergillosis in Critically Ill Patients with COVID-19: A Systematic Review and Meta-Analysis
Conference abstract · 28 Dec 2020
Non-pharmacological interventions to reduce the incidence and duration of delirium in critically ill patients: A systematic review and network meta-analysis
Research article · 16 Jul 2019
Delirium in the Critically Ill Patients: Is It Easily Diagnosed? What is the Incidence and What is the Management?
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 24 Feb 2025
Combining Urinary Biomarker Panels and Machine Learning For Earlier Detection of Pancreatic Cancer
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Maria Teresa Mascellino”
